BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20650889)

  • 21. Mucopolysaccharidosis type IIIC in chinese mainland: clinical and molecular characteristics of ten patients and report of six novel variants in the HGSNAT gene.
    Liang Y; Gao X; Lu D; Zhang H; Zhang
    Metab Brain Dis; 2023 Aug; 38(6):2013-2023. PubMed ID: 37014526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the biosynthesis, processing and kinetic mechanism of action of the enzyme deficient in mucopolysaccharidosis IIIC.
    Fan X; Tkachyova I; Sinha A; Rigat B; Mahuran D
    PLoS One; 2011; 6(9):e24951. PubMed ID: 21957468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first Korean case of mucopolysaccharidosis IIIC (Sanfilippo syndrome type C) confirmed by biochemical and molecular investigation.
    Huh HJ; Seo JY; Cho SY; Ki CS; Lee SY; Kim JW; Park HD; Jin DK
    Ann Lab Med; 2013 Jan; 33(1):75-9. PubMed ID: 23301227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological characterization of retinal degeneration in mucopolysaccharidosis type IIIC.
    Ludwig J; Sawant OB; Wood J; Singamsetty S; Pan X; Bonilha VL; Rao S; Pshezhetsky AV
    Exp Eye Res; 2023 Apr; 229():109433. PubMed ID: 36858249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.
    Marcó S; Pujol A; Roca C; Motas S; Ribera A; Garcia M; Molas M; Villacampa P; Melia CS; Sánchez V; Sánchez X; Bertolin J; Ruberte J; Haurigot V; Bosch F
    Dis Model Mech; 2016 Sep; 9(9):999-1013. PubMed ID: 27491071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update of the spectrum of mucopolysaccharidoses type III in Tunisia: identification of three novel mutations and in silico structural analysis of the missense mutations.
    Ouesleti S; Coutinho MF; Ribeiro I; Miled A; Mosbahi DS; Alves S
    World J Pediatr; 2017 Aug; 13(4):374-380. PubMed ID: 28101780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl coenzyme A: alpha-glucosaminide N-acetyltransferase. Evidence for a transmembrane acetylation mechanism.
    Bame KJ; Rome LH
    J Biol Chem; 1985 Sep; 260(20):11293-9. PubMed ID: 3897232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.
    Klein U; Kresse H; von Figura K
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5185-9. PubMed ID: 33384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An acetylated 120-kDa lysosomal transmembrane protein is absent from mucopolysaccharidosis IIIC fibroblasts: a candidate molecule for MPS IIIC.
    Ausseil J; Landry K; Seyrantepe V; Trudel S; Mazur A; Lapointe F; Pshezhetsky AV
    Mol Genet Metab; 2006 Jan; 87(1):22-31. PubMed ID: 16293432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetyl-coenzyme A:alpha-glucosaminide N-acetyltransferase. Evidence for an active site histidine residue.
    Bame KJ; Rome LH
    J Biol Chem; 1986 Aug; 261(22):10127-32. PubMed ID: 3733705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Heparan sulfate acetyl-CoA: Alpha-glucosaminide N-acetyltransferase (HGSNAT) inactivation on the structure and function of epithelial and immune cells of the testis and epididymis and sperm parameters in adult mice.
    Carvelli L; Hermo L; O'Flaherty C; Oko R; Pshezhetsky AV; Morales CR
    PLoS One; 2023; 18(9):e0292157. PubMed ID: 37756356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and mechanism of lysosome transmembrane acetylation by HGSNAT.
    Xu R; Ning Y; Ren F; Gu C; Zhu Z; Pan X; Pshezhetsky AV; Ge J; Yu J
    Nat Struct Mol Biol; 2024 May; ():. PubMed ID: 38769387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC.
    O'Leary C; Forte G; Mitchell NL; Youshani AS; Dyer A; Wellby MP; Russell KN; Murray SJ; Jolinon N; Jones SA; Stacey K; Davis DM; Henckaerts E; Palmer DN; Kamaly-Asl I; Bigger BW
    J Transl Med; 2023 Jul; 21(1):437. PubMed ID: 37407981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome).
    Hrebícek M; Mrázová L; Seyrantepe V; Durand S; Roslin NM; Nosková L; Hartmannová H; Ivánek R; Cízkova A; Poupetová H; Sikora J; Urinovská J; Stranecký V; Zeman J; Lepage P; Roquis D; Verner A; Ausseil J; Beesley CE; Maire I; Poorthuis BJ; van de Kamp J; van Diggelen OP; Wevers RA; Hudson TJ; Fujiwara TM; Majewski J; Morgan K; Kmoch S; Pshezhetsky AV
    Am J Hum Genet; 2006 Nov; 79(5):807-19. PubMed ID: 17033958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of MPS IIIA, MPS IIIB and MPS IIIC in Tunisian patients.
    Ouesleti S; Brunel V; Ben Turkia H; Dranguet H; Miled A; Miladi N; Ben Dridi MF; Lavoinne A; Saugier-Veber P; Bekri S
    Clin Chim Acta; 2011 Nov; 412(23-24):2326-31. PubMed ID: 21910976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands.
    Ruijter GJ; Valstar MJ; van de Kamp JM; van der Helm RM; Durand S; van Diggelen OP; Wevers RA; Poorthuis BJ; Pshezhetsky AV; Wijburg FA
    Mol Genet Metab; 2008 Feb; 93(2):104-11. PubMed ID: 18024218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycosaminoglycans and mucopolysaccharidosis type III.
    Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human acetyl-coenzyme A:alpha-glucosaminide N-acetyltransferase. Kinetic characterization and mechanistic interpretation.
    Meikle PJ; Whittle AM; Hopwood JJ
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):327-33. PubMed ID: 7755582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.
    Martins C; Hůlková H; Dridi L; Dormoy-Raclet V; Grigoryeva L; Choi Y; Langford-Smith A; Wilkinson FL; Ohmi K; DiCristo G; Hamel E; Ausseil J; Cheillan D; Moreau A; Svobodová E; Hájková Z; Tesařová M; Hansíková H; Bigger BW; Hrebícek M; Pshezhetsky AV
    Brain; 2015 Feb; 138(Pt 2):336-55. PubMed ID: 25567323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of exogenously added acetyl coenzyme A by intact isolated lysosomes.
    Rome LH; Hill DF; Bame KJ; Crain LR
    J Biol Chem; 1983 Mar; 258(5):3006-11. PubMed ID: 6402508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.